We are currently enrolling patients for multiple studies:

  • Predictors of microsurgical varicocele ligation, and mechanisms of male infertility
  • We are part of a nationwide Andrology Research Consortium evaluating etiologies, treatments, and outcomes for male infertility
  • A study combining Bacillus Calmette-Guerin (BCG) with ALT-803, an immunomodulator, in patients undergoing treatment for non-muscle invasive bladder cancer. More information.
  • A phase 3 study to evaluate the efficacy and tolerability of Vicinium in patients with Non Muscle-Invasive Carcinoma in Situ (CIS) and/or High Grade Papillary disease of the bladder previously treated with Bacillus Calmette-Guerin (BCG) More information. 
  • A registry for treatment of upper urinary tract tumors. This project captures information related to the diagnosis of Upper Urinary Tract Tumors, and submitted to a database that is controlled by the Clinical Research Office of the Endourologic Society.
  • The Rare Diseases Clinical Network provides funding for our study on cystinuria patients with kidney stone disease.
  • A phase II trial to assess the safety and effectiveness of Bucillamine on urinary cystine excretion and cystine capacity in patients with cystinuria. More information.
  • A phase III, randomized trial that will assess the efficacy and safety of 600 or 800 units of Dysport injected into the bladder for the treatment of Neurogenic Detrusor Overactivity due to Spinal Cord Injury of Multiple Sclerosis. More information.